These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 16638163)

  • 1. A review of the alpha-1 foundation: its formation, impact, and critical success factors.
    Walsh JW; Snider GL; Stoller JK
    Respir Care; 2006 May; 51(5):526-31. PubMed ID: 16638163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Key current clinical issues in alpha-1 antitrypsin deficiency.
    Stoller JK
    Respir Care; 2003 Dec; 48(12):1216-21; discussion 1221-4. PubMed ID: 14651762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The personal and professional benefits of the ENT Nursing Foundation.
    Sievers AE; Sievers MS; Johnson B
    ORL Head Neck Nurs; 2009; 27(3):13-5. PubMed ID: 19714954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alpha-1 antitrypsin deficiency, a corporate perspective.
    Stern LD
    COPD; 2013 Mar; 10 Suppl 1():54-6. PubMed ID: 23527855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Hartford Geriatric Nursing Initiative: developing a focused strategy and strong partnerships to improve nursing care for older adults.
    Watman R; Escobedo M; Langston CA
    Nurs Outlook; 2011; 59(4):182-7. PubMed ID: 21757070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Formation and current results of a patient-organized registry for alpha(1)-antitrypsin deficiency.
    Stoller JK; Brantly M; Fleming LE; Bean JA; Walsh J
    Chest; 2000 Sep; 118(3):843-8. PubMed ID: 10988213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Responsible patient advocacy: perspectives from the Alpha-1 Foundation.
    Sharp RR; Yarborough M; Walsh JW;
    Am J Med Genet A; 2008 Nov; 146A(22):2845-50. PubMed ID: 18932220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Foundation's consumer advocacy health reform initiative strengthened groups' effectiveness.
    Strong D; Lipson D; Honeycutt T; Kim J
    Health Aff (Millwood); 2011 Sep; 30(9):1799-803. PubMed ID: 21900672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Field building: lessons from the Robert Wood Johnson Foundation's anthology series.
    Isaacs SL; Knickman JR
    Health Aff (Millwood); 2005; 24(4):1161-5. PubMed ID: 16012156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An interview with Steven A. Schroeder.
    Schroeder SA
    Nurs Econ; 1991; 9(6):383-90, 400. PubMed ID: 1956425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of alpha-1 antitrypsin deficiency: a review.
    Aboussouan LS; Stoller JK
    Respir Med; 2009 Mar; 103(3):335-41. PubMed ID: 19013782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hospital foundations: pros and cons should be considered.
    Bachrach B
    Fund Raising Manage; 1978; 9(3):36-9, 50-1. PubMed ID: 10308094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Orthopaedic research and education foundation and industry.
    Wurth GR; Sherr JH; Coffman TM
    Clin Orthop Relat Res; 2003 Jul; (412):54-6. PubMed ID: 12838052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. "Monkeys, babies, idiots" and "primitives": nature-nurture debates and philanthropic foundation support for American anthropology in the 1920s and 1930s.
    Biehn KJ
    J Hist Behav Sci; 2009; 45(3):219-35. PubMed ID: 19575386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Some reflections on a few of the pitfalls in the world of foundation grant making.
    Billings J
    Health Aff (Millwood); 2007; 26(6):1772-5. PubMed ID: 17978397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Special event a "pushover" for Hemophilia Foundation.
    Harrington TD
    Fund Raising Manage; 1978; 9(5):26-8. PubMed ID: 10318421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Issues in the diagnosis of alpha 1-antitrypsin deficiency.
    Rachelefsky G; Hogarth DK
    J Allergy Clin Immunol; 2008 Apr; 121(4):833-8. PubMed ID: 18313128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancing the engagement of U.S. private foundations with conservation science.
    Zavaleta E; Miller DC; Salafsky N; Fleishman E; Webster M; Gold B; Hulse D; Rowen M; Tabor G; Vanderryn J
    Conserv Biol; 2008 Dec; 22(6):1477-84. PubMed ID: 18847442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Augmentation therapy for emphysema due to alpha-1-antitrypsin deficiency.
    Tirado-Conde G; Lara B; Miravitlles M
    Ther Adv Respir Dis; 2008 Feb; 2(1):13-21. PubMed ID: 19124355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Foundation-industry relationships--a new business model joint-venture philanthropy in therapy development.
    Bartek RJ
    Curr Top Med Chem; 2014; 14(3):313-8. PubMed ID: 24283968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.